Maziar Mike Doustdar appointed President and CEO of Novo Nordisk
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
He has previously served in pivotal HR leadership roles at RPG Life Sciences, Akumentis Healthcare, and Wockhardt
The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
Singhal brings a powerful blend of operational excellence, investor acumen, and visionary thinking
His career spans notable tenures at Syngene International Limited, Cipla, Nestlé, and Bharat Petroleum Corporation Limited
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
Subscribe To Our Newsletter & Stay Updated